Thrombin receptor expression in normal and atherosclerotic human arteries.
about
Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient miceRestricted expression of homeobox genes distinguishes fetal from adult human smooth muscle cellsChanges in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesionAgonist-stimulated cytoskeletal reorganization and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src.An integrated mathematical model of thrombin-, histamine-and VEGF-mediated signalling in endothelial permeability.Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells.Protein targets of inflammatory serine proteases and cardiovascular disease.Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury.Protease activated receptors: theme and variations.Plasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors.Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women: a critical mediator of vascular dysfunction.Is thrombin a key player in the 'coagulation-atherogenesis' maze?Molecular mapping of the heparin-binding exosite of thrombin.Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.Constitutive expression and modulation of the functional thrombin receptor in the human kidney.Contractile actions of thrombin receptor-derived polypeptides in human umbilical and placental vasculature: evidence for distinct receptor systemsThe cleaved peptide of the thrombin receptor is a strong platelet agonist.Protease-activated receptors in cancer: A systematic review.Multiple Signaling Pathways Contribute to the Thrombin-induced Secretory Phenotype in Vascular Smooth Muscle Cells.Protease activation of calcium-independent phospholipase A2 leads to neutrophil recruitment to coronary artery endothelial cellsA novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production.Matrix metalloproteases and PAR1 activation.Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension.Noncanonical matrix metalloprotease-1-protease-activated receptor-1 signaling triggers vascular smooth muscle cell dedifferentiation and arterial stenosis.Concentration dependent dual effect of thrombin in endothelial cells via Par-1 and Pi3 Kinase.Receptor tyrosine kinase EphA2 mediates thrombin-induced upregulation of ICAM-1 in endothelial cells in vitro.Novel role for p21-activated kinase 2 in thrombin-induced monocyte migration.Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impactThrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promotVentilation and oxygenation induce endothelial nitric oxide synthase gene expression in the lungs of fetal lambs.SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.Vascular PAR-1: activity and antagonism.Vorapaxar: a novel protease-activated receptor-1 inhibitor.The role of the host defense system in the development of cerebral vasospasm: analogies between atherosclerosis and subarachnoid hemorrhage.Emerging roles for native Orai Ca2+ channels in cardiovascular diseaseThrombin generation and atherosclerosis.Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study.G-protein-mediated signaling in vascular smooth muscle cells - implications for vascular disease.Coagulation, Fibrinolysis, and Platelet Activation Following Open Surgical or Percutaneous Angioplasty Revascularization for Symptomatic Lower Limb Chronic Ischemia.
P2860
Q24309637-E9978EB2-24C7-4492-9CA0-5689927C1019Q24680458-F4DE21D4-1273-459C-8AE7-914582201F13Q28273856-83EF0F5F-F696-484E-857E-06C815DF1709Q28582819-FA809A8F-CADA-4927-850A-6CF79144E5C8Q33843980-B2152505-5064-4D23-A4E2-1788DEC7E062Q33960909-993DCBE7-FEB4-49CC-9504-7AC8CFB30685Q34034262-508B2E6C-4BCC-433E-99F5-14A26FDE8732Q34114355-4737ED61-9E5E-4659-906A-855A2218560FQ34125318-CE768618-9979-4051-A6BA-BC5963E72995Q34225983-18B1E10C-2659-4F65-B951-3C8FF0168969Q34251521-A45E695D-6065-4518-AD84-515FABEAAE72Q34760729-345B81D8-03E3-4D07-8211-D0F45EEDDB43Q34948467-67242526-C4F9-4DA8-BABD-DB11F6DB51CFQ35478768-776A49C3-C820-4CD6-9EBD-679D19ECBD7DQ35620514-DC92C22C-DB0B-4CCC-8C12-A3B6E5C642D2Q35797967-7A0EF067-97EF-4BD8-A62E-ABE05F0FEB5FQ35872196-07ABAC14-1F96-4BA6-AC22-6C88412F57FEQ35979576-0C474CD3-6DDC-4E00-9C35-F7002D7A4116Q36121203-2259DC52-5573-4003-8A1D-9479CC7C05EFQ36260759-19D95437-3017-471A-B191-8D268BC4D124Q36319224-3866A7CF-C323-40F6-80D8-BE38886A340CQ36363072-04B04F4D-95DC-47BB-82E7-DBF1CCC43802Q36542806-E690B846-B4BF-460B-8C16-081472A528EEQ36769644-69B100EE-3BEC-48A2-BE1D-A0E10D10E726Q37095396-962A0C13-9DB2-47B0-9544-78B4786B28B9Q37146006-509CCC33-C77B-4F99-8B8B-CAA2F7FFA26FQ37197931-8328175B-E15D-41B4-B4AB-F402DCF86108Q37312105-45B6492A-C5B9-4BAB-8A50-E66DD5A8DD49Q37348262-A7795777-D66D-4C6E-87F2-D95E20DD9B4EQ37352355-2F4C6483-DACF-4BB6-B04A-9A9E68B08785Q37372504-58C6DAD9-E34D-4CE1-AD25-E55D90487281Q37617543-309A47C3-8A57-4E26-AD52-A152232AFCBCQ37763262-D8321996-6198-4C2B-B0C8-6AFE4B7E4CFAQ37912186-B16B3BAE-4D4A-4DD3-8881-F48E785F127AQ38055310-646388F9-57E6-4E8B-B5A6-B3B117EF2057Q38124446-C29B1493-5B3B-4506-A4E4-2B7EAC84BA77Q38163395-CE247EE6-5E37-433D-948C-64E1AEE3DA16Q38376637-C1EFA7CD-5794-4F24-8955-50BEF52E25B2Q38526491-05C681E2-4ABD-49B9-B471-F12DAFBEF3BCQ38840257-F91B8A59-E63A-4404-AA30-35579964AD10
P2860
Thrombin receptor expression in normal and atherosclerotic human arteries.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Thrombin receptor expression in normal and atherosclerotic human arteries.
@ast
Thrombin receptor expression in normal and atherosclerotic human arteries.
@en
type
label
Thrombin receptor expression in normal and atherosclerotic human arteries.
@ast
Thrombin receptor expression in normal and atherosclerotic human arteries.
@en
prefLabel
Thrombin receptor expression in normal and atherosclerotic human arteries.
@ast
Thrombin receptor expression in normal and atherosclerotic human arteries.
@en
P2093
P2860
P356
P1476
Thrombin receptor expression in normal and atherosclerotic human arteries.
@en
P2093
P2860
P304
P356
10.1172/JCI116031
P407
P577
1992-10-01T00:00:00Z